Скачать или смотреть Psilocybin Is Rewiring the Brain: Stanford Research, Real Healing, and What Happens Next

This week’s live Buena Vida webinar is led by Mina, our facilitator currently studying psilocybin at Stanford University.She’ll break down how psilocybin supports healing and change by increasing neuroplasticity, calming the Default Mode Network, and loosening the rigid mental patterns tied to anxiety, depression, and chronic stress.

You’ll get a clear explanation of what actually happens in the brain, why these shifts matter, and how this research connects to real therapeutic outcomes.Short session. Straightforward science. Open Q&A at the end. We’ll break down the core mechanisms behind psychedelic-assisted transformation:

• Neuroplasticity: how psilocybin temporarily increases the brain’s capacity to form new pathways, learn faster, and interrupt engrained emotional loops
• Default Mode Network: what it is, why it becomes overactive in anxiety, depression, trauma, and burnout, and how psilocybin quiets rigid self-referential patterns
• Pattern disruption: how psychedelics interrupt repetitive thinking, expand cognitive flexibility, and create space for new behaviors
• Emotional processing: why long-buried material becomes accessible and workable under safe guidance
• Integration: what actually locks in change after the experience, and why breathwork and somatic practices matter

This session is designed for people exploring psychedelic therapy, nervous system healing, burnout recovery, trauma resolution, and high-stress life transitions. It’s also relevant for anyone researching psychedelic science, psilocybin clinical trials, or the future of mental health treatments.

Keywords woven through the content: psychedelic therapy, psilocybin research, Stanford University, neuroplasticity, Default Mode Network, anxiety and depression healing, trauma recovery tools, nervous system regulation, psychedelic neuroscience, mental health innovation, somatic practices, breathwork integration, burnout recovery, emotional resilience, psychedelic-assisted therapy, brain rewiring, consciousness studies.

Mina Caraccio is a researcher and clinician with a background in cognitive science and a specialized focus on psychedelic studies. She earned her B.S. in Cognitive Science from Yale University and is currently completing her doctoral training through the PAU–Stanford University Psy.D. Consortium, where her work centers on psilocybin, ethics, and the emerging landscape of psychedelic-assisted therapies.

Her research includes published work on consent, cultural context, and the medicalization of psychedelic use, most notably in her paper Psychedelics Beyond Medicine: Treatment, Enhancement, Hype, Consent, and the Limits of Medicalization. Mina’s ongoing clinical and academic work bridges neuroscience, therapeutic practice, and the rapidly evolving science of psychedelic medicine.